Hoshino, Junichi http://orcid.org/0000-0002-0444-101X
Tsunoda, Ryoya
Nagai, Kei
Kai, Hirayasu
Saito, Chie
Ito, Yukiko
Asahi, Koichi
Kondo, Masahide
Iseki, Kunitoshi
Iseki, Chiho
Okada, Hirokazu
Kashihara, Naoki
Narita, Ichiei
Wada, Takashi
Combe, Christian
Pisoni, Ronald L.
Robinson, Bruce M.
Yamagata, Kunihiro
Funding for this research was provided by:
Japan Agency for Medical Research and Development
Japan Society for the Promotion of Science (15K08719, 18K08227)
Okinaka Memorial Institute for Medical Research
Article History
Received: 5 September 2020
Accepted: 22 March 2021
First Online: 21 April 2021
Declarations
:
: J.H. has received a research grant from Otsuka Pharmaceutical Co. H.O is funded by Takeda Pharm., Chugai Pharm., Kyowa-Hakko Kirin, Pfizer, Boehinger Ingelheim, Astellas Pharm., Otsuka Pharm., MSD, Shionogi, Novaltis, Sumitomo Dainippon Pharm., Mitsubishi Tanabe Pharm., and Daiichi Sankyo Co. B.R and R.P. are members of Clinical Research for the non-profit organization Arbor Research Collaborative for health, which has designed and carried out the Dialysis Outcomes and Practice Pattern Study (DOPPS) Program. The DOPPS program is supported by Amgen, Kyowa Hakko Kirin, AbbVie Inc., Sanofi Renal, Baxter Healthcare, and Vifor Fresenius Medical Care Renal Pharma Ltd. Additional support for specific projects and countries is also provided in Canada by Amgen, BHC Medical, Janssen, Takeda, Kidney Foundation of Canada (for logistics support); in Germany by Hexal, DGfN, Shire, WiNe Institute; and for the Peritoneal-DOPPS in Japan by the Japanese Society for Peritoneal Dialysis (JSPD). The DOPPS.org website lists the full details. JDOPPS was administered by the Arbor Research Collaborative for Health, Ann Arbor, MI, USA, and supported by Kyowa Hakko Kirin Co. Ltd. All support is provided without restrictions on publications. All other authors have no conflict disclosure.
: The study’s protocol was approved by the Tsukuba institutional review board (IRB) (H27-199) and the review board of the Japanese Society of Nephrology (No. 29), and has been or will be approved by the IRB of each participating facility. The study procedures fully adhered to the Declaration of Helsinki and the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement, and was registered with the University Hospital Medical Information Network (UMIN000022145).
: Informed consent was and will be obtained from all individual participants included in the study.